Drugs / modified oxide diallyl disulfide
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02632877 | Jan 2014 → Nov 2015 | ulcer of lower limbs | University of Guadalajara | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | modified oxide diallyl disulfide | “Active ingredients: Pirfenidone 8% with modified oxide diallyl disulfide (MODD) 0.016%.” NCT02632877 ↗ |
| Known as | MODD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02632877 ↗ |